| Research Topics: |
| INDEX |
| AI-chat 6 |
| MCS 2 |
| PRIME 42 |
| PRIO 5 |
| aging 10 |
| body 2 |
| brain 9 |
| cancer 7 |
| climate 5 |
| cognition 6 |
| covid-19 4 |
| crime 1 |
| culture 3 |
| dental 1 |
| diabetes 3 |
| diagnostics 1 |
| disease 1 |
| drugs 5 |
| economy 6 |
| exercise 2 |
| eyes 1 |
| genetics 6 |
| gut 1 |
| heart 8 |
| immune 2 |
| language 1 |
| law 2 |
| lyme 1 |
| metabolism 3 |
| microbiome 2 |
| misc 1 |
| nutrition 9 |
| obesity 3 |
| pain 4 |
| physical 2 |
| politics 3 |
| pollution 3 |
| practice 4 |
| psychology 9 |
| quantum 4 |
| religion 1 |
| rights 1 |
| sleep 2 |
| vaccine 1 |
| virus 1 |
|
Scanned: 1729 Evaluated: 336 Selected: 88 Back Issue Map |
| PRIME BRAIN DIABETES OBESITY | ||||||||
Ps380-006 | Ozempic: Starving the Brain Into Early Dementia | |||||||
| Quote: | "If your dietary quality doesnt improve on these drugs, then you are definitely going to run into an issue of complete undernourishment. So when you take these medications, every single meal counts more than if you werent taking them." | |||||||
| Article: | https://principia-scientific.com/ozempic-starving-the-brain-into-early-dementia/ | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| PRIME DIABETES OBESITY | ||||||||
Sd380-013 | Zepbound and Mounjaro May Turn on the Bodys Calorie-Burning Brown Fat | |||||||
| Quote: | Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drugs powerful benefits and inspire more comprehensive treatments for obesity and diabetes. | |||||||
| Article: | https://www.sciencedaily.com//releases/2026/09/260925093210.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| PRIME DIABETES | ||||||||
Sd391-002 | Diabetes Study Finds Keeping Blood Sugar Too Steady May Come at a Price | |||||||
| Quote: | The findings, which will be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28 - Oct. 2), indicate that people with type 1 or type 2 diabetes sometimes reported a better quality of life after days when their glucose levels fluctuated more, provided those levels remained within safe limits. | |||||||
| Article: | https://www.sciencedaily.com//releases/2026/09/260927225019.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
|
Javilk's Research Links Newsletter for Week 39 Updated 10/03/2026-03:08:04 AM Back Issue Topic Map What interests you? What have you found? Tell me! Drop me a note at Javilk.com to subscribe or submit something. |